An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
NCT07179055 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2025-09-17
Summary
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Conditions
- Dry Eye
Interventions
- DRUG
-
VSJ-110
ophthalmic solution
- DRUG
-
ophthalmic solution
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-31
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study of ST-100 as Treatment for Dry Eye Disease
NCT05241470 ·Status: COMPLETED ·Phase: PHASE2
-
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of the Clinical Utility and Safety of the Visant Medical Canalicular Plug
NCT04817085 ·Status: COMPLETED ·Phase: NA
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT05370495 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease
NCT03597139 ·Status: COMPLETED ·Phase: PHASE2
-
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
NCT05759208 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01211951 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
NCT04092907 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Center Study Subjects With Dry Eye Syndrome
NCT01745887 ·Status: COMPLETED ·Phase: PHASE1
-
A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01890941 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
NCT03162094 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
NCT01239069 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.
NCT00784719 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome
NCT04206020 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
NCT01960010 ·Status: COMPLETED ·Phase: PHASE3
-
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01118754 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
NCT01427816 ·Status: COMPLETED ·Phase: PHASE2
-
Levocarnitine for Dry Eye in Sjogren's Syndrome
NCT03953703 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
NCT05238597 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
NCT00739349 ·Status: COMPLETED ·Phase: PHASE2
-
Study of VVN001 Ophthalmic Solution in Dry Eye Disease
NCT04556838 ·Status: COMPLETED ·Phase: PHASE2